<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Small bowel <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (SBA) is a rare <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and consequently, the options for clinical trials are limited </plain></SENT>
<SENT sid="1" pm="."><plain>As they are treated according to either a colorectal or a <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> regimen and the molecular biology of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is a pivotal determinant for therapy response, chromosomal copy number aberrations were compared with the colorectal and <z:mp ids='MP_0008010'>gastric adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Materials and methods: A total of 85 microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> from the stomach, colorectum and small bowel were selected from existing array comparative genomic hybridization (aCGH) datasets </plain></SENT>
<SENT sid="3" pm="."><plain>We compared the aCGH profiles of the three <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sites by supervised analysis and hierarchical clustering </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Hierarchical clustering revealed substantial overlap of 27 SBA copy number profiles with matched colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> but less overlap with profiles of <z:mp ids='MP_0008010'>gastric adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>DNA copy number aberrations located at chromosomes 1p36.3-p34.3, 4p15.3-q35.2, 9p24.3-p11.1, 13q13.2-q31.3 and 17p13.3-p13.2 were the strongest features discriminating SBAs and colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> from <z:mp ids='MP_0008010'>gastric adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: We show that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> SBAs are more similar to colorectal than to <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, based on the 27 genome-wide DNA copy number profiles that are currently available </plain></SENT>
<SENT sid="7" pm="."><plain>These molecular similarities provide added support for treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> <z:e sem="disease" ids="C0153425" disease_type="Neoplastic Process" abbrv="">small bowel cancers</z:e> according to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> regimens </plain></SENT>
</text></document>